Raydiant Oximetry, Inc, raised a $5m Series A2 financing led by Avestria Ventures, with participation from KOFA Healthcare, V-Capital, Band of Angels, FemHealth Ventures, RHIA Ventures and SteelSky Ventures. Raydiant Oximetry is a clinical-stage medical device company focused on improving women’s and neonatal health. Its innovation is LUMERAHTM, the non-invasive fetal oximeter designed to detect fetal distress during labor and delivery. It is an investigational medical device that is not currently approved for commercial sale. Read full article